Aurora-A regulation of nuclear factor-κB signaling by phosphorylation of IκBα

被引:93
|
作者
Briassouli, Paraskevi
Chan, Florence
Savage, Kay
Reis-Filho, Jorge S.
Linardopoulos, Spiros
机构
[1] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London SW3 6JB, England
[2] Canc Res UK, Inst Canc Res, Ctr Canc Therapeut, Belmont, Surrey, England
关键词
D O I
10.1158/0008-5472.CAN-06-2272
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Aurora-A/STK15 gene encodes a kinase that is frequently amplified in cancer. Overexpression of Aurora-A in mammalian cells leads to centrosome amplification, genetic instability, and transformation. In this study, we show that Aurora-A activates nuclear factor-kappa B (NF-kappa B) via I kappa B alpha phosphorylation. Inhibition of endogenous Aurora-A reduces tumor necrosis factor alpha (TNF alpha)-induced I kappa B alpha degradation. We analyzed primary human breast cancers, and 13.6% of samples showed Aurora-A gene amplification, all of which exhibited nuclear localization of NF-kappa B. We propose that this subgroup of patients with breast cancer might benefit from inhibiting Aurora-A. We also show that down-regulation of NF-kappa B via Aurora-A depletion can enhance cisplatin-dependent apoptosis. These data define a new role for Aurora-A in regulating I kappa B alpha that is critical for the activation of NF-kappa B-directed gene expression and may be partially responsible for the oncogenic effect of Aurora-A when the gene is amplified and overexpressed in human tumors.
引用
收藏
页码:1689 / 1695
页数:7
相关论文
共 50 条
  • [21] Localization of nuclear factor-κB (NFκB) and inhibitory factor-κB (IκB) in human fetal membranes and decidua at term and preterm delivery
    Yan, X
    Sun, M
    Gibb, W
    PLACENTA, 2002, 23 (04) : 288 - 293
  • [22] Negative regulation of nuclear factor-κB activation and function by glucocorticoids
    Almawi, WY
    Melemedjian, OK
    JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2002, 28 (02) : 69 - 78
  • [23] Endotoxin, but not platelet-activating factor, activates nuclear factor-κB and increases IκBα and IκBβ turnover in enterocytes
    de Plaen, IG
    Qu, XW
    Wang, H
    Tan, XD
    Wang, LY
    Han, XB
    Rozenfeld, RA
    Hsueh, W
    IMMUNOLOGY, 2002, 106 (04) : 577 - 583
  • [24] Silica induces nuclear factor-κB activation through tyrosine phosphorylation of IκB-α in RAW264.7 macrophages
    Kang, JL
    Pack, IS
    Hong, SM
    Lee, HS
    Castranova, V
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 2000, 169 (01) : 59 - 65
  • [25] Receptor activator of nuclear factor-κB ligand activates nuclear factor-κB in osteoclast precursors
    Wei, S
    Teitelbaum, SL
    Wang, MWH
    Ross, FP
    ENDOCRINOLOGY, 2001, 142 (03) : 1290 - 1295
  • [26] Nuclear factor-κB inhibition in sepsis:: Steroids versus specific nuclear factor-κb inhibitors?
    Marik, PE
    CRITICAL CARE MEDICINE, 2002, 30 (10) : 2393 - 2394
  • [27] Role of Nuclear Factor-κB (NF-κB) in the Regulation of IκB Kinase ε (IKKε) Expression in Human Pulmonary Epithelial Cells
    Necker-Brown, A.
    Thorne, A.
    Bansal, A.
    Mostafa, M. M.
    Gerber, A. N.
    Newton, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] Negative Feedback Regulation of Aurora-A via Phosphorylation of Fas-associated Factor-1
    Jang, Moon-Sun
    Sul, Jee-Won
    Choi, Byung-Jung
    Lee, Su-Jin
    Suh, Jee-Hee
    Kim, Nam-Soon
    Kim, Woo Ho
    Lim, Dae-Sik
    Lee, Chang-Woo
    Kim, Eunhee
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (47) : 32344 - 32351
  • [29] Inhibition of nuclear transcription factor-κB by specific IκB kinase peptide inhibitor
    Swaroop, N
    Chen, F
    Wang, LY
    Dokka, S
    Toledo, D
    Rojanasakul, Y
    PHARMACEUTICAL RESEARCH, 2001, 18 (11) : 1631 - 1633
  • [30] Inhibition of Nuclear Transcription Factor-κB by Specific IκB Kinase Peptide Inhibitor
    Navin Swaroop
    Fei Chen
    Liying Wang
    Sujatha Dokka
    David Toledo
    Yon Rojanasakul
    Pharmaceutical Research, 2001, 18 : 1631 - 1633